"10.1371_journal.pone.0150806","plos one","2016-04-08T00:00:00Z","Lihua Zhang; Jing Li; Xi Li; Khurram Nasir; Haibo Zhang; Yongjian Wu; Shuang Hu; Qing Wang; Nicholas S Downing; Nihar R Desai; Frederick A Masoudi; John A Spertus; Harlan M Krumholz; Lixin Jiang; China PEACE Collaborative Group","National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Peoples Republic of China; Center for Healthcare Advancement & Outcomes, Baptist Health South Florida, Miami, Florida, United States of America; Miami Cardiac & Vascular Institute, Baptist Health South Florida, Miami, Florida, United States of America; The Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut, United States of America; Division of Cardiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America; Saint Lukes Mid America Heart Institute, University of Missouri Kansas City, Kansas City, Missouri, United States of America; Section of Cardiovascular Medicine and the Robert Wood Johnson Clinical Scholars Program, Department of Internal Medicine, Yale University School of Medicine, New Haven, United States of America; Department of Health Policy and Management, Yale School of Public Health, New Haven, United States of America","Conceived and designed the experiments: HMK LXJ JL XL FAM JAS. Performed the experiments: JL XL LXJ LHZ HBZ. Analyzed the data: SH QW. Contributed reagents/materials/analysis tools: SH QW XL. Wrote the paper: LHZ JL KN HBZ YJW NSD NRD FAM JAS HMK LXJ.","The funders from the National Health and Family Planning Commission of China and the Center for Cardiovascular Outcomes Research at Yale University had no any relevant conflicts of interest. Dr. Krumholz reports being the recipient of research grants from Medtronic and Johnson & Johnson, through Yale University, to develop methods of clinical trial data sharing, for Medtronic, to develop device surveillance methods in collaboration with the Food and Drug Administration, and the chair of a cardiac scientific advisory board for United Health Care. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials","2016","04","Lihua Zhang","LZ",15,TRUE,6,5,2,11,TRUE,FALSE,TRUE,1,"15",TRUE
